Background
Celiac disease (CD) is an autoimmune disorder of the small intestine in which dietary gluten ingestion leads to a chronic inflammatory status of the mucosa [
1]. There is strong evidence for a genetic component for CD, with the HLA genes being the strongest genetic locus associated with CD predisposition known to date. About 95% of CD patients are carriers of the DQ2 molecule, encoded by DQA1*05/DQB1*02 alleles, compared to ~10% of healthy control subjects. Furthermore, the DQ8 molecule (DQA1*0301/DQB1*0302 is also found more frequently in CD patients although to a lesser extent [
2]. Finally, a role for genes located outside the HLA region has been suggested since the overall contribution of HLA genes to CD genetic predisposition is no more than 40% [
1].
T CD4+ lymphocytes are key elements in the induction and progression of CD pathogenesis. Certain gluten peptides bound to DQ2 or DQ8 molecules cause proliferation and production of proinflammatory cytokines by lamina propria CD4 +T cells [
3]. Besides this activation of adaptive immune response, recent evidences suggest that there is an implication of the innate immunity in the initial phases of CD [
4]. In this regard, some gluten peptides have been demonstrated to drive a danger signal that leads to an activation of the innate immune system [
5,
6] and additionally it is thought that bacteria may play a role in CD [
7]. In fact, CD patients show an up-regulation in the expression of pro-inflammatory cytokines typically related to the innate immune response, such us IL1, IL-18 and chemokines [
6,
8‐
10].
The IL1 gene cluster located in the chromosomal region 2q12-22 codifies for three proteins: IL-1α, IL-1β and IL-1 receptor agonist (IL-1RN), of which the two first are strong inducers of inflammation while IL-1RN is an effective antagonist binding to the IL-1 receptor without activating the target cell [
11]. These genes are polymorphic bearing well-characterized single nucleotide polymorphisms (SNPs). Polymorphisms in IL-1α at position -889 C/T (rs1800587) and IL-1β at position -511 C/T (rs1143627) were described [
12,
13]. Furthermore, recent findings showed that the -511 C/T IL-1β genetic variant is related to differences in IL-1β protein secretion [
14]. The
IL-1RN gene contains within its second intron a variable number of an 86-bp tandem repeats (rs380092) [
15], showing the allele 2 (IL-1RN*2; two repeats) an increased frequency in a variety of autoimmune and inflammatory disorders [
16].
Another important member of the proinflammatory IL-1 family is IL-18, which is thought to be a key regulator of cytokine expression [
17]. Furthermore, a role for IL-18 in the induction of an anti-gluten inflammatory response has been suggested [
10,
18,
19]. It is thought that IL-18 gene variation in the promoter region regulates the expression of this cytokine [
20]. Interestingly, in the IL-18 promoter region two SNPs -607 A/C (rs1946518) and -137 G/C (rs187238) were described, which are supposed to alter the IL-18 promoter activity [
21].
Moreover, raised levels of chemokines such us RANTES (regulated upon activation, normal T-cells expressed and secreted) and monocyte chemoatractant protein-1 (MCP-1) have been observed in the primary immune response to gluten in CD patients [
6,
8]. Interestingly, genetic variants within regulatory regions that can affect trancription and protein production levels,
RANTES -403 G/A (rs2107538) and -28 G/C (rs2280788) and
MCP-1 -2518 G/A (rs1024611) SNPs, were described [
22‐
24].
Taking into consideration these findings, in this work we aimed to investigate the possible implication of IL-1α, IL-1β, IL-1RN, IL-18, RANTES and MCP-1 functional polymorphisms in CD susceptibility.
Discussion
CD is considered a model for autoimmune disorders since many of the components that generate the altered immune response to gluten have been well characterized [
1]. However, there are some relevant events of CD pathogenesis that remain unclear, for instance the stimuli that drives the high IFNγ levels in the small intestine of CD patients and why only one out of 20–30 DQ2-positive individuals develops CD [
3]. An explanation for these questions might be provided from recent studies that point out a role for the innate immunity in CD [
4]. This finding supports a novel focus of research in CD molecular and genetic basis, opening a new field for the functional search of CD candidate genes.
In this work, for the first time we have assessed the relevance of
IL-1α, IL-1β, IL-1RN, IL-18, RANTES and
MCP-1 genes in CD predisposition. All these genes have been previously associated with susceptibility to several autoimmune disorders [
31‐
40]. However, we failed to detect an association of
IL-1α, IL-1β, IL-1RN, IL-18, and
MCP-1 genes with CD predisposition using a TDT analysis in our cohort of 105 simplex CD families. Only a borderline significant association of
RANTES promoter genetic variants with CD predisposition was observed.
Several studies have focused on the role of
RANTES -403G/A and -28 G/C promoter polymorphisms in susceptibility to different autoimmune disorders. The
RANTES -403A allele has been associated with susceptibility to multiple sclerosis (MS) and polymialgia rheumatica [
41,
42]. On the other hand, the
RANTES -28G allele was observed to be a genetic risk for clinical complications such us diabetic neprhopathy, early onset of MS, lower levels of C3 in SLE, and higher incidence of central nervous system lupus [
37,
38,
41]. Both
RANTES -403A and -28G alleles were associated with higher RANTES expression levels [
22,
23]. However, considering the multiple testing of the 6 different genes of our study, the association observed for
RANTES promoter variants in our population can not be considered as being significant. Therefore, our results of
RANTES suggest that further studies should be performed to clarify the role of
RANTES in CD and autoimmune diseases in general.
Using a familial approach we eliminate the risk of population stratification derived from case-control association studies. In addition, we estimated that our study design would have considerable power to detect the effect of a polymorphism with moderate to high risk for CD. Assuming an additive model, a minor allele frequency of 0.30 (corresponding to a median value of the majority of markers considered) and RR of 1.8 we would reach 81% power to detect an association in our population. Nevertheless, under a dominant model the power drops to 49% and considering a lower disease allele frequency, for instance 0.16 as is the case of RANTES -28, our study power would decrease to a 64% for a RR of 1.8, and increases to 82% when we assume a RR of 2.0. For this reason, the low level of significance that our TDT analysis reached for RANTES promoter genetic variants might well reflect a true positive, and therefore needs further confirmation using a larger group of CD families.
Taking into account our findings, it is suggested that the analysed genetic polymorphisms of
IL-1α, IL1-β, IL-1RN, IL-18, RANTES and
MCP-1 genes seem not to play a major role in CD susceptibility in our population. It might be possible that the release of these cytokines and chemokines observed in CD patients could be derived from the activity of other innate immunity related pro-inflammatory mediators with higher influence in disease pathogenesis. In this regard, it is known that in CD the cytokine expression pattern in response to gluten is strongly dominated by IFNγ [
43]. Of note, in a recent work we assessed the influence of a functional dinucleotide polymorphism of IFNγ gene in CD predisposition. An association of a higher IFNγ producer allele with CD was observed, supporting a possible explanation for the high levels of INFγ observed in intestinal mucosa of CD patients [
44].
Other proinflammatory mediators related with innate immunity such as, TNF-α and IL-12, has been analysed with respect to CD susceptibility. In accordance with our findings no evidence of association was found between IL-12 and CD in two independent studies [
45,
46]. Regarding TNF-α it has been difficult to dissect the relevance of this genetic marker in CD since it maps within HLA clas III region and it shows linkage disequilibrium with CD disease predisposing DQ2 alleles. In fact controversial results have been obtained, and there is no consensus about an independent or due to linkage disequilibrium role of TNF-α in CD susceptibility [
47,
48].
Conclusion
Our results suggest that IL-1α, IL1-β, IL-1RN, IL-18, RANTES and MCP-1 genetic variants do not play a major role in CD genetic predisposition, although the suggestive evidence for RANTES deserves further investigation. Furthermore, we consider the innate response an intriguing focus of research and it should be of interest to investigate the role of other cytokines up-regulated in the early events of CD.
Acknowledgements
This work was supported by grant SAF03-460 from Plan Nacional de I+D (CICYT), and in part by Consejería de Educación, Junta de Andalucía, grupo CTS-180.
B.K. is supported by the Dutch Diabetes Research Foundation, The Netherlands Organisation for Health Research and Development (ZonMW) and The Juvenile Diabetes Research Foundation International (JDRF) (2001.10.004).
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
B.R., carried out the genotyping and statistical analysis and drafted the manuscript.
A.Z., participated in the genotyping and helped in the use of the ABI PRIM 7900 Sequence Detection Systems and SDS 2.2.1 software.
M.A. L-N., collected the samples and revised the manuscript.
J.M., participated in the manuscript design and coordination and helped to draft the manuscript
B.K., reviewed the statistical analysis and helped to draft the manuscript.
All authors read and approved the final manuscript.